Wyss Center partners with Artiria Medical to accelerate a novel therapy for cerebral vasospasm .

Are you developing a promising technology in the field of applied neuroscience or neurotechnology? Do you intend to bring it to the market? This joint EPFL-Wyss Center call for projects might be for you.

Results demonstrate MRI compatibility, good surgical handling and reliable recording in bioelectronic interfaces that conform to the nervous system .

Geneva, Switzerland - The Wyss Center has joined forces with an international consortium of universities, biomedical startups and nonprofit organizations to develop therapies for spinal cord injury that could improve long-term recovery.

Revealing details of the internal structure of 'mini-brains' could help accelerate drug studies and may offer alternatives to some animal testing .

The Wyss Center's spin-off company Epios joins a global network of entrepreneurs with its long-term brain monitoring technology .

The results could help clinicians understand addiction and enable people to better manage substance withdrawal .

Could a ray of light stop rogue proteins in their tracks and slow the spread of neurodegenerative disease in the brain? EPFL and the Wyss Center are set to find out.

Charter group of 21 world-class institutions representing a network of over 150,000 researchers across six continents sign agreement that sets new bar for fast-paced research and development.

To do this, Baud collaborated with Vikram Rao, neurologist at UCSF, to obtain neuronal activity data collected over several years using devices implanted long-term in the brains of patients with epilepsy.